CN105533712A - Composition used for increasing bone density and enhancing immunity - Google Patents
Composition used for increasing bone density and enhancing immunity Download PDFInfo
- Publication number
- CN105533712A CN105533712A CN201511025471.9A CN201511025471A CN105533712A CN 105533712 A CN105533712 A CN 105533712A CN 201511025471 A CN201511025471 A CN 201511025471A CN 105533712 A CN105533712 A CN 105533712A
- Authority
- CN
- China
- Prior art keywords
- powder
- composition
- bone density
- vitamin
- increasing bone
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 239000000203 mixture Substances 0.000 title claims abstract description 35
- 230000037182 bone density Effects 0.000 title claims abstract description 32
- 230000036039 immunity Effects 0.000 title abstract description 6
- 230000002708 enhancing effect Effects 0.000 title abstract 2
- 102000008186 Collagen Human genes 0.000 claims abstract description 24
- 108010035532 Collagen Proteins 0.000 claims abstract description 24
- 229920001436 collagen Polymers 0.000 claims abstract description 24
- 229910052500 inorganic mineral Inorganic materials 0.000 claims abstract description 22
- 239000011707 mineral Substances 0.000 claims abstract description 22
- 239000011782 vitamin Substances 0.000 claims abstract description 21
- 229940088594 vitamin Drugs 0.000 claims abstract description 21
- 229930003231 vitamin Natural products 0.000 claims abstract description 21
- 235000013343 vitamin Nutrition 0.000 claims abstract description 21
- 108090000765 processed proteins & peptides Proteins 0.000 claims abstract description 17
- 101710093543 Probable non-specific lipid-transfer protein Proteins 0.000 claims abstract description 15
- 229940036811 bone meal Drugs 0.000 claims abstract description 15
- 239000002374 bone meal Substances 0.000 claims abstract description 15
- 239000000843 powder Substances 0.000 claims description 59
- OYPRJOBELJOOCE-UHFFFAOYSA-N Calcium Chemical compound [Ca] OYPRJOBELJOOCE-UHFFFAOYSA-N 0.000 claims description 21
- 239000011575 calcium Substances 0.000 claims description 21
- 229910052791 calcium Inorganic materials 0.000 claims description 21
- 150000003722 vitamin derivatives Chemical class 0.000 claims description 19
- 235000020243 first infant milk formula Nutrition 0.000 claims description 13
- XEEYBQQBJWHFJM-UHFFFAOYSA-N Iron Chemical compound [Fe] XEEYBQQBJWHFJM-UHFFFAOYSA-N 0.000 claims description 12
- VYZAMTAEIAYCRO-UHFFFAOYSA-N Chromium Chemical compound [Cr] VYZAMTAEIAYCRO-UHFFFAOYSA-N 0.000 claims description 10
- RYGMFSIKBFXOCR-UHFFFAOYSA-N Copper Chemical compound [Cu] RYGMFSIKBFXOCR-UHFFFAOYSA-N 0.000 claims description 10
- FYYHWMGAXLPEAU-UHFFFAOYSA-N Magnesium Chemical compound [Mg] FYYHWMGAXLPEAU-UHFFFAOYSA-N 0.000 claims description 10
- HCHKCACWOHOZIP-UHFFFAOYSA-N Zinc Chemical compound [Zn] HCHKCACWOHOZIP-UHFFFAOYSA-N 0.000 claims description 10
- 229910052804 chromium Inorganic materials 0.000 claims description 10
- 239000011651 chromium Substances 0.000 claims description 10
- 229910052802 copper Inorganic materials 0.000 claims description 10
- 239000010949 copper Substances 0.000 claims description 10
- 235000013399 edible fruits Nutrition 0.000 claims description 10
- 239000011777 magnesium Substances 0.000 claims description 10
- 229910052749 magnesium Inorganic materials 0.000 claims description 10
- 239000011701 zinc Substances 0.000 claims description 10
- 229910052725 zinc Inorganic materials 0.000 claims description 10
- VYPSYNLAJGMNEJ-UHFFFAOYSA-N Silicium dioxide Chemical compound O=[Si]=O VYPSYNLAJGMNEJ-UHFFFAOYSA-N 0.000 claims description 8
- 229910052742 iron Inorganic materials 0.000 claims description 6
- 239000000463 material Substances 0.000 claims description 5
- -1 15 parts Chemical compound 0.000 claims description 4
- 239000005913 Maltodextrin Substances 0.000 claims description 4
- 229920002774 Maltodextrin Polymers 0.000 claims description 4
- VDTNNGKXZGSZIP-UHFFFAOYSA-N carbutamide Chemical compound CCCCNC(=O)NS(=O)(=O)C1=CC=C(N)C=C1 VDTNNGKXZGSZIP-UHFFFAOYSA-N 0.000 claims description 4
- 235000013339 cereals Nutrition 0.000 claims description 4
- 239000013078 crystal Substances 0.000 claims description 4
- 229940035034 maltodextrin Drugs 0.000 claims description 4
- 239000000377 silicon dioxide Substances 0.000 claims description 4
- WVXRAFOPTSTNLL-NKWVEPMBSA-N 2',3'-dideoxyadenosine Chemical compound C1=NC=2C(N)=NC=NC=2N1[C@H]1CC[C@@H](CO)O1 WVXRAFOPTSTNLL-NKWVEPMBSA-N 0.000 claims description 3
- 244000298697 Actinidia deliciosa Species 0.000 claims description 3
- 235000009436 Actinidia deliciosa Nutrition 0.000 claims description 3
- 244000144730 Amygdalus persica Species 0.000 claims description 3
- 244000099147 Ananas comosus Species 0.000 claims description 3
- 235000007119 Ananas comosus Nutrition 0.000 claims description 3
- 235000004936 Bromus mango Nutrition 0.000 claims description 3
- 241001133958 Calyptronoma plumeriana Species 0.000 claims description 3
- 235000005979 Citrus limon Nutrition 0.000 claims description 3
- 244000131522 Citrus pyriformis Species 0.000 claims description 3
- 240000000560 Citrus x paradisi Species 0.000 claims description 3
- 244000060011 Cocos nucifera Species 0.000 claims description 3
- 235000013162 Cocos nucifera Nutrition 0.000 claims description 3
- 235000016623 Fragaria vesca Nutrition 0.000 claims description 3
- 240000009088 Fragaria x ananassa Species 0.000 claims description 3
- 235000011363 Fragaria x ananassa Nutrition 0.000 claims description 3
- 240000006053 Garcinia mangostana Species 0.000 claims description 3
- 235000017048 Garcinia mangostana Nutrition 0.000 claims description 3
- 244000157072 Hylocereus undatus Species 0.000 claims description 3
- 235000018481 Hylocereus undatus Nutrition 0.000 claims description 3
- 240000003394 Malpighia glabra Species 0.000 claims description 3
- 235000014837 Malpighia glabra Nutrition 0.000 claims description 3
- 240000007228 Mangifera indica Species 0.000 claims description 3
- 235000014826 Mangifera indica Nutrition 0.000 claims description 3
- 235000011925 Passiflora alata Nutrition 0.000 claims description 3
- 235000000370 Passiflora edulis Nutrition 0.000 claims description 3
- 235000011922 Passiflora incarnata Nutrition 0.000 claims description 3
- 240000002690 Passiflora mixta Species 0.000 claims description 3
- 235000013750 Passiflora mixta Nutrition 0.000 claims description 3
- 235000013731 Passiflora van volxemii Nutrition 0.000 claims description 3
- OAICVXFJPJFONN-UHFFFAOYSA-N Phosphorus Chemical compound [P] OAICVXFJPJFONN-UHFFFAOYSA-N 0.000 claims description 3
- 235000006040 Prunus persica var persica Nutrition 0.000 claims description 3
- 241000508269 Psidium Species 0.000 claims description 3
- 235000009184 Spondias indica Nutrition 0.000 claims description 3
- 239000012141 concentrate Substances 0.000 claims description 3
- 235000012907 honey Nutrition 0.000 claims description 3
- 239000011574 phosphorus Substances 0.000 claims description 3
- 229910052698 phosphorus Inorganic materials 0.000 claims description 3
- ZOXJGFHDIHLPTG-UHFFFAOYSA-N Boron Chemical compound [B] ZOXJGFHDIHLPTG-UHFFFAOYSA-N 0.000 claims description 2
- DGAQECJNVWCQMB-PUAWFVPOSA-M Ilexoside XXIX Chemical compound C[C@@H]1CC[C@@]2(CC[C@@]3(C(=CC[C@H]4[C@]3(CC[C@@H]5[C@@]4(CC[C@@H](C5(C)C)OS(=O)(=O)[O-])C)C)[C@@H]2[C@]1(C)O)C)C(=O)O[C@H]6[C@@H]([C@H]([C@@H]([C@H](O6)CO)O)O)O.[Na+] DGAQECJNVWCQMB-PUAWFVPOSA-M 0.000 claims description 2
- ZLMJMSJWJFRBEC-UHFFFAOYSA-N Potassium Chemical compound [K] ZLMJMSJWJFRBEC-UHFFFAOYSA-N 0.000 claims description 2
- BUGBHKTXTAQXES-UHFFFAOYSA-N Selenium Chemical compound [Se] BUGBHKTXTAQXES-UHFFFAOYSA-N 0.000 claims description 2
- 229910052796 boron Inorganic materials 0.000 claims description 2
- PNDPGZBMCMUPRI-UHFFFAOYSA-N iodine Chemical compound II PNDPGZBMCMUPRI-UHFFFAOYSA-N 0.000 claims description 2
- WPBNNNQJVZRUHP-UHFFFAOYSA-L manganese(2+);methyl n-[[2-(methoxycarbonylcarbamothioylamino)phenyl]carbamothioyl]carbamate;n-[2-(sulfidocarbothioylamino)ethyl]carbamodithioate Chemical compound [Mn+2].[S-]C(=S)NCCNC([S-])=S.COC(=O)NC(=S)NC1=CC=CC=C1NC(=S)NC(=O)OC WPBNNNQJVZRUHP-UHFFFAOYSA-L 0.000 claims description 2
- 239000011591 potassium Substances 0.000 claims description 2
- 229910052700 potassium Inorganic materials 0.000 claims description 2
- 239000011669 selenium Substances 0.000 claims description 2
- 229910052711 selenium Inorganic materials 0.000 claims description 2
- 229910052708 sodium Inorganic materials 0.000 claims description 2
- 239000011734 sodium Substances 0.000 claims description 2
- 230000036737 immune function Effects 0.000 abstract description 5
- 210000002540 macrophage Anatomy 0.000 abstract description 5
- 241000282414 Homo sapiens Species 0.000 abstract description 4
- 108060003951 Immunoglobulin Proteins 0.000 abstract description 3
- 102000018358 immunoglobulin Human genes 0.000 abstract description 3
- 210000004698 lymphocyte Anatomy 0.000 abstract description 2
- 210000004180 plasmocyte Anatomy 0.000 abstract description 2
- 210000003022 colostrum Anatomy 0.000 abstract 2
- 235000021277 colostrum Nutrition 0.000 abstract 2
- 230000007071 enzymatic hydrolysis Effects 0.000 abstract 2
- 238000006047 enzymatic hydrolysis reaction Methods 0.000 abstract 2
- 210000004369 blood Anatomy 0.000 abstract 1
- 239000008280 blood Substances 0.000 abstract 1
- 210000004204 blood vessel Anatomy 0.000 abstract 1
- 210000002865 immune cell Anatomy 0.000 abstract 1
- 239000000126 substance Substances 0.000 abstract 1
- 230000009044 synergistic interaction Effects 0.000 abstract 1
- 210000000988 bone and bone Anatomy 0.000 description 12
- 238000002474 experimental method Methods 0.000 description 8
- 241000700159 Rattus Species 0.000 description 6
- 238000012360 testing method Methods 0.000 description 6
- VTYYLEPIZMXCLO-UHFFFAOYSA-L Calcium carbonate Chemical compound [Ca+2].[O-]C([O-])=O VTYYLEPIZMXCLO-UHFFFAOYSA-L 0.000 description 4
- 239000013642 negative control Substances 0.000 description 4
- 210000000689 upper leg Anatomy 0.000 description 4
- 230000000694 effects Effects 0.000 description 3
- 239000012467 final product Substances 0.000 description 3
- 230000036541 health Effects 0.000 description 3
- 238000002360 preparation method Methods 0.000 description 3
- 238000005303 weighing Methods 0.000 description 3
- DHMQDGOQFOQNFH-UHFFFAOYSA-N Glycine Chemical compound NCC(O)=O DHMQDGOQFOQNFH-UHFFFAOYSA-N 0.000 description 2
- PMMYEEVYMWASQN-DMTCNVIQSA-N Hydroxyproline Chemical compound O[C@H]1CN[C@H](C(O)=O)C1 PMMYEEVYMWASQN-DMTCNVIQSA-N 0.000 description 2
- 241001465754 Metazoa Species 0.000 description 2
- 238000010521 absorption reaction Methods 0.000 description 2
- 230000002146 bilateral effect Effects 0.000 description 2
- 230000037396 body weight Effects 0.000 description 2
- 210000002805 bone matrix Anatomy 0.000 description 2
- 229910000019 calcium carbonate Inorganic materials 0.000 description 2
- CADZRPOVAQTAME-UHFFFAOYSA-L calcium;hydroxy phosphate Chemical compound [Ca+2].OOP([O-])([O-])=O CADZRPOVAQTAME-UHFFFAOYSA-L 0.000 description 2
- 210000004027 cell Anatomy 0.000 description 2
- 239000003795 chemical substances by application Substances 0.000 description 2
- PMMYEEVYMWASQN-UHFFFAOYSA-N dl-hydroxyproline Natural products OC1C[NH2+]C(C([O-])=O)C1 PMMYEEVYMWASQN-UHFFFAOYSA-N 0.000 description 2
- 238000005516 engineering process Methods 0.000 description 2
- 238000003304 gavage Methods 0.000 description 2
- 235000013402 health food Nutrition 0.000 description 2
- 229960002591 hydroxyproline Drugs 0.000 description 2
- 230000006698 induction Effects 0.000 description 2
- 238000002347 injection Methods 0.000 description 2
- 239000007924 injection Substances 0.000 description 2
- 210000002751 lymph Anatomy 0.000 description 2
- 238000000034 method Methods 0.000 description 2
- 210000001616 monocyte Anatomy 0.000 description 2
- 210000001672 ovary Anatomy 0.000 description 2
- VLTRZXGMWDSKGL-UHFFFAOYSA-N perchloric acid Chemical compound OCl(=O)(=O)=O VLTRZXGMWDSKGL-UHFFFAOYSA-N 0.000 description 2
- 210000000952 spleen Anatomy 0.000 description 2
- FGMPLJWBKKVCDB-UHFFFAOYSA-N trans-L-hydroxy-proline Natural products ON1CCCC1C(O)=O FGMPLJWBKKVCDB-UHFFFAOYSA-N 0.000 description 2
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Chemical compound O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 2
- LOTKRQAVGJMPNV-UHFFFAOYSA-N 1-fluoro-2,4-dinitrobenzene Chemical compound [O-][N+](=O)C1=CC=C(F)C([N+]([O-])=O)=C1 LOTKRQAVGJMPNV-UHFFFAOYSA-N 0.000 description 1
- 206010002091 Anaesthesia Diseases 0.000 description 1
- 102000010834 Extracellular Matrix Proteins Human genes 0.000 description 1
- 108010037362 Extracellular Matrix Proteins Proteins 0.000 description 1
- 241000287828 Gallus gallus Species 0.000 description 1
- 239000004471 Glycine Substances 0.000 description 1
- 108010006464 Hemolysin Proteins Proteins 0.000 description 1
- ONIBWKKTOPOVIA-BYPYZUCNSA-N L-Proline Chemical compound OC(=O)[C@@H]1CCCN1 ONIBWKKTOPOVIA-BYPYZUCNSA-N 0.000 description 1
- GRYLNZFGIOXLOG-UHFFFAOYSA-N Nitric acid Chemical compound O[N+]([O-])=O GRYLNZFGIOXLOG-UHFFFAOYSA-N 0.000 description 1
- 208000001132 Osteoporosis Diseases 0.000 description 1
- 229930182555 Penicillin Natural products 0.000 description 1
- JGSARLDLIJGVTE-MBNYWOFBSA-N Penicillin G Chemical compound N([C@H]1[C@H]2SC([C@@H](N2C1=O)C(O)=O)(C)C)C(=O)CC1=CC=CC=C1 JGSARLDLIJGVTE-MBNYWOFBSA-N 0.000 description 1
- 241000219000 Populus Species 0.000 description 1
- ONIBWKKTOPOVIA-UHFFFAOYSA-N Proline Natural products OC(=O)C1CCCN1 ONIBWKKTOPOVIA-UHFFFAOYSA-N 0.000 description 1
- 210000000683 abdominal cavity Anatomy 0.000 description 1
- 238000009825 accumulation Methods 0.000 description 1
- 239000002253 acid Substances 0.000 description 1
- 150000001413 amino acids Chemical class 0.000 description 1
- 230000037005 anaesthesia Effects 0.000 description 1
- 238000004458 analytical method Methods 0.000 description 1
- 230000008485 antagonism Effects 0.000 description 1
- 238000003556 assay Methods 0.000 description 1
- 230000009286 beneficial effect Effects 0.000 description 1
- 235000013361 beverage Nutrition 0.000 description 1
- 230000015572 biosynthetic process Effects 0.000 description 1
- 230000017531 blood circulation Effects 0.000 description 1
- 230000001413 cellular effect Effects 0.000 description 1
- 230000008859 change Effects 0.000 description 1
- 239000008367 deionised water Substances 0.000 description 1
- 229910021641 deionized water Inorganic materials 0.000 description 1
- 238000001514 detection method Methods 0.000 description 1
- 230000029087 digestion Effects 0.000 description 1
- 210000003743 erythrocyte Anatomy 0.000 description 1
- 238000011156 evaluation Methods 0.000 description 1
- 230000003203 everyday effect Effects 0.000 description 1
- 210000002744 extracellular matrix Anatomy 0.000 description 1
- 238000009472 formulation Methods 0.000 description 1
- 239000003228 hemolysin Substances 0.000 description 1
- 229910052588 hydroxylapatite Inorganic materials 0.000 description 1
- 230000000527 lymphocytic effect Effects 0.000 description 1
- 239000011159 matrix material Substances 0.000 description 1
- 210000003205 muscle Anatomy 0.000 description 1
- 229910017604 nitric acid Inorganic materials 0.000 description 1
- 238000009806 oophorectomy Methods 0.000 description 1
- 210000004409 osteocyte Anatomy 0.000 description 1
- 239000002245 particle Substances 0.000 description 1
- 229940049954 penicillin Drugs 0.000 description 1
- XYJRXVWERLGGKC-UHFFFAOYSA-D pentacalcium;hydroxide;triphosphate Chemical compound [OH-].[Ca+2].[Ca+2].[Ca+2].[Ca+2].[Ca+2].[O-]P([O-])([O-])=O.[O-]P([O-])([O-])=O.[O-]P([O-])([O-])=O XYJRXVWERLGGKC-UHFFFAOYSA-D 0.000 description 1
- 210000003024 peritoneal macrophage Anatomy 0.000 description 1
- 210000002381 plasma Anatomy 0.000 description 1
- 230000002980 postoperative effect Effects 0.000 description 1
- 239000000047 product Substances 0.000 description 1
- 238000003908 quality control method Methods 0.000 description 1
- 210000002966 serum Anatomy 0.000 description 1
- QGMRQYFBGABWDR-UHFFFAOYSA-N sodium;5-ethyl-5-pentan-2-yl-1,3-diazinane-2,4,6-trione Chemical compound [Na+].CCCC(C)C1(CC)C(=O)NC(=O)NC1=O QGMRQYFBGABWDR-UHFFFAOYSA-N 0.000 description 1
- 239000007787 solid Substances 0.000 description 1
- 239000000243 solution Substances 0.000 description 1
- 230000002195 synergetic effect Effects 0.000 description 1
- 238000003786 synthesis reaction Methods 0.000 description 1
- 210000001694 thigh bone Anatomy 0.000 description 1
- 210000001541 thymus gland Anatomy 0.000 description 1
- 230000009466 transformation Effects 0.000 description 1
- 230000007306 turnover Effects 0.000 description 1
- 238000011121 vaginal smear Methods 0.000 description 1
- 230000002792 vascular Effects 0.000 description 1
- 210000001835 viscera Anatomy 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2002/00—Food compositions, function of food ingredients or processes for food or foodstuffs
Landscapes
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Coloring Foods And Improving Nutritive Qualities (AREA)
Abstract
The invention provides a composition used for increasing bone density and enhancing immunity. The composition is prepared by mixing collagen peptide, bone meal subjected to enzymatic hydrolysis, colostrum basic protein and vitamins, and the collagen peptide, bone meal subjected to enzymatic hydrolysis, colostrum basic protein, vitamins and mineral substances in the composition are combined with one another and have synergistic interaction to increase the bone density remarkably; meanwhile, while flowing through each part of a body along with blood, immune cells penetrate through a blood vessel wall to get close to external foreign matters so as to be timely combined with the collagen peptide, so that an immune function to the foreign matters, macrophage, lymphocyte, plasma cells, immune globulin and the like is generally improved, and therefore, the immunity of a human body is improved.
Description
Technical field
The present invention relates to a kind of health-related composition, especially a kind of for increasing bone density and the composition of develop immunitypty.
Background technology
Bone is the complicated organism be made up of bone matrix and bone mineral.The main component of bone matrix is collagen, and the main component of bone mineral is calcium hydroxy phosphate.First the generation of bone is synthesis collagen, collagenous fibres are intertwined to form matrix net, then calcium, phosphorus are deposited in collagen stroma net with the form of calcium hydroxy phosphate, therefore do not have ossein just can not Cheng Qiwei bone in bone, and be the accumulation of many hydroxyapatite molecules and particle, not having enough osseins carrying out eubolism in bone, will be not strong and unsound.
Collagen is rich in the amino acid such as glycine, proline, hydroxyproline that human body needs.Collagen is most important part in extracellular matrix.Calcium in blood plasma is still transported to the delivery vehicle of osteocyte by hydroxyproline contained in collagen.If lack collagen, prevent and treat osteoporosis with replenishing the calcium merely, more calcium also cannot improve.
The height of body immunity is called that with some the raw body molecule of immunoglobulin (Ig) is relevant, as lymph corpuscle and macrophage, when alien material is invaded, immunocyte is general just like army, can put up a resistance to alien material, surrounded by foreign matter and engulf, even self-sacrifice is healthy to keep.So immunocyte is strongr, and external enemy just can kill and subtracts by number enough words completely, otherwise health will be made sick.
Summary of the invention
Technical problem to be solved by this invention is to provide a kind of for increasing bone density and the composition of develop immunitypty.
For solving the problems of the technologies described above, technical scheme of the present invention is:
A kind of for increasing bone density and the composition of develop immunitypty, it is characterized in that, said composition is made up of collagen peptide, enzymolysis bone meal, first milk basic protein, vitamin and mineral matter, by its weight parts collagen peptide 10-60 part, enzymolysis bone meal 10-50 part, first milk basic protein 0.1-3 part, vitamin 0.01-1 part, mineral matter 0.01-1 part; Wherein, described mineral matter is one or more in calcium, sodium, zinc, phosphorus, potassium, magnesium, manganese, copper, boron, chromium, iron, iodine, selenium, and described vitamin is any combination of one or more in VA, VC, VD, VE, VK, VB race.
Preferably, above-mentioned for increasing bone density and the composition of develop immunitypty, by its weight parts collagen peptide 20-50 part, enzymolysis bone meal 20-40 part, first milk basic protein 0.5-2.5 part, vitamin 0.05-0.8 part, mineral matter 0.05-0.8 part.
Preferably, above-mentioned for increasing bone density and the composition of develop immunitypty, by its weight parts collagen peptide 30-40 part, enzymolysis bone meal 25-35 part, first milk basic protein 1-2 part, vitamin 0.1-0.5 part, mineral matter 0.1-0.5 part.
Preferably, for increasing bone density and the composition of develop immunitypty, it is characterized in that, by its weight parts collagen peptide 15 parts, enzymolysis bone meal 15 parts, first milk basic protein 1 part, vitamin 0.1 part, 0.1 part, mineral matter.
Preferably, described mineral matter is made up of calcium, zinc, magnesium, copper, chromium and iron, by its weight parts calcium 80 parts, 1 part, zinc, 15 parts, magnesium, copper 0.1 part, chromium 0.01 part.
Preferably, described vitamin is made up of VA, VC, VD, VE, VK, by its weight parts VA10 part, VC1000 part, VD0.1 part, VE1000 part, VK1 part.
For increasing bone density and the composition of develop immunitypty, also comprise cereal and reconstitute powder, crystal diabetin, Fruit powder, maltodextrin and silica composition, reconstitute powder 1-95 part, crystal diabetin 1-50 part, Fruit powder 1-40 part, maltodextrin 1-20 part, silica 0.1-2 part by its weight parts cereal.
Preferably, described Fruit powder is any combination of one or more in apple powder, kiwi fruit powder, mangosteen powder, coconut powder, mango powder, passionflower powder, pineapple powder, honey peach powder, manaca powder, acerola concentrate powder, A Sayi fruit powder, grape fruit powder, guava powder, lemon powder, strawberry powder, dragon fruit powder.
Above-mentioned for increasing bone density and the preparation method of the composition of develop immunitypty, concrete preparation process is as follows:
(1) each component in prescription is taken by prescription amount for subsequent use;
(2) each component is mixed, to obtain final product.
The invention has the beneficial effects as follows:
Above-mentioned for increasing bone density and the composition of develop immunitypty, collagen peptide, enzymolysis bone meal, first milk basic protein, vitamin and mineral matter be combined with each other, each component Synergistic, increase bone density Be very effective, simultaneously when immunocyte with blood flow through health everywhere time, can through vascular wall, be combined in time with collagen peptide close to immunocyte during external foreign matter, antagonism foreign matter, macrophage, lymph corpuscle, the immunity function such as plasma cell and immunoglobulin (Ig) bulking property promotes, increase resistance of human body, adopt solid beverage formulation, mouthfeel is good, easy absorption, be convenient to take, its preparation method is simple, is applicable to the needs that large-scale industrial is produced.
Detailed description of the invention
Below in conjunction with specific embodiment, technical scheme of the present invention is further described.
Embodiment 1
For increasing bone density and a composition for develop immunitypty, be made up of collagen peptide, enzymolysis bone meal, first milk basic protein, vitamin and mineral matter, concrete consumption is in table 1, and described composition is obtained by following method:
(1) each component in prescription is taken by prescription amount for subsequent use;
(2) each component is mixed, to obtain final product.
Table 1
Described mineral matter is made up of calcium, zinc, magnesium, copper, chromium and iron, by its weight parts calcium 80 parts, 1 part, zinc, 15 parts, magnesium, copper 0.1 part, chromium 0.01 part; Described vitamin is made up of VA, VC, VD, VE, VK, by its weight parts VA10 part, VC1000 part, VD0.1 part, VE1000 part, VK1 part.
Embodiment 2
A kind of for increasing bone density and the composition of develop immunitypty, reconstituted powder, crystal diabetin, Fruit powder, maltodextrin, first milk basic protein, vitamin, mineral matter and silica formed by collagen peptide, enzymolysis bone meal, cereal, concrete consumption is in table 2, and described composition is obtained by following method:
(1) each component in prescription is taken by prescription amount for subsequent use;
(2) each component is mixed, to obtain final product.
Table 2
Described mineral matter is made up of calcium, zinc, magnesium, copper, chromium and iron, by its weight parts calcium 80 parts, 1 part, zinc, 15 parts, magnesium, copper 0.1 part, chromium 0.01 part; Described vitamin is made up of VA, VC, VD, VE, VK, by its weight parts VA10 part, VC1000 part, VD0.1 part, VE1000 part, VK1 part; Described Fruit powder is combined by the weight ratio such as apple powder, kiwi fruit powder, mangosteen powder, coconut powder, mango powder, passionflower powder, pineapple powder, honey peach powder, manaca powder, acerola concentrate powder, A Sayi fruit powder, grape fruit powder, guava powder, lemon powder, strawberry powder and dragon fruit powder and obtains.
Efficacy experiments:
Sample: composition described in embodiment 1-1.
One, bone density experiment is increased
(1) oophorectomize: rat, with dosage lumbar injection 1% Nembutal sodium solution of 30mg/kgbw, carries out Bilateral oophorectomy after anesthesia, the penicillin of postoperative muscle injection 20,000 units, for three days on end.Sham-operation group only excises 0.5g fat after opening abdominal cavity, retains bilateral ovaries.Latter 5 days of rat ovary excision, carries out vaginal smear examination, rejects the incomplete rat of oophorectomize.
(2) animal grouping: above-mentioned female castrated rats is divided into basic, normal, high three the dosage groups of model control group, high dose calcium carbonate control group and sample at random by body weight.Set up sham-operation group simultaneously.Often organize 10, single cage is raised, and feeds 3 months.
(3) thighbone density measures: at the end of experiment, and rat is put to death in the dislocation of strength vertebra, peels off right femur, through 105 DEG C of bakings 8 hours, after being cooled to room temperature, measures the bone density (BMD) of femur midpoint and distal end.
(4) calcium content of bone measures: after weighing the gross weight of femur, put into the triangular flask through HCl treatment dry cleansing, add nitric acid+perchloric acid (4:1) mixed acid 15ml, deionized water constant volume is used after digestion, measure calcium content of bone with atomic absorption spectrophotometer, each mensuration makes Quality Control material by the GBW07604 Poplar leaves of State Bureau of Technical Supervision's approval.
(5) test data statistics: carry out variance analysis with SPSS software.
(6) result judges: not based on the product of replenishing the calcium (can contain a small amount of calcium), model control group calcium content of bone or bone density, significantly lower than sham-operation group, show to cause the low drag of rat bone density; The calcium content of bone of oophorectomize+animal subject group or bone density comparatively model control group significantly increase, and be not less than the calcium carbonate control group of corresponding dosage, and other indexs (except body weight) are not significantly lower than model control group, can judge that this tested material has the effect increasing bone density.Experimental result is in table 3.
Table 3
Experimental result shows: calcium content of bone, femur center density, femur distal end density are significantly higher than model control group P < 0.05, and this given the test agent (embodiment 1-1 composition) has the effect increasing bone density.
Two, develop immunitypty experiment
(1) calculate a dosage group and a negative control group according to day for human beings taking dose, give and corresponding dosage, negative control group gives pure water, every day gavage once, continuous gavage 30-35d.
(2) internal organs/weight ratio pH-value determination pH: test is end eventually, the mouse of weighing after putting to death, takes out Thymus and spleen, at scales/electronic balance weighing, calculates dirty/body ratio
(3) the mouse spleen lymphocyte transformation experiment of ConA induction, test is end eventually, carries out lymphocytic multiplication capacity detection by mtt assay.
(4) the mouse DTH experiment of dinitrofluorobenzene induction
(5) mensuration of serum hemolysin and antibody-producting cell detect
(6) mouse carbonic clearance experiment
(7) Turnover of Mouse Peritoneal Macrophages engulfs chicken red blood cell experiment
(8) result judges: the requirement evaluated according to health food, positive in any two in cellular immune function, humoral immune function, monocytes/macrophages function, NK cytoactive four, can judge that this given the test agent (embodiment 1-1 composition) has develop immunitypty function.Experimental result is in table 4.
Table 4
Test shows, sample compares with negative control group mouse cell immunologic function, humoral immune function, monocytes/macrophages function, difference has statistical significance (P < 0.05), to NK cytoactive no significant difference compared with negative control group.The requirement of health food evaluation judges that this sample has the effect increasing immunity.
Above-mentioned with reference to embodiment to this for increasing bone density and the composition of the develop immunitypty detailed description of carrying out; illustrative instead of determinate; several embodiments can be listed according to institute's limited range; therefore in the change do not departed under general plotting of the present invention and amendment, should belong within protection scope of the present invention.
Claims (8)
1. one kind for increasing bone density and the composition of develop immunitypty, it is characterized in that, said composition is made up of collagen peptide, enzymolysis bone meal, first milk basic protein, vitamin and mineral matter, by its weight parts collagen peptide 10-60 part, enzymolysis bone meal 10-50 part, first milk basic protein 0.1-3 part, vitamin 0.01-1 part, mineral matter 0.01-1 part;
Described mineral matter is one or more in calcium, sodium, zinc, phosphorus, potassium, magnesium, manganese, copper, boron, chromium, iron, iodine, selenium;
Described vitamin is one or more in VA, VC, VD, VE, VK, VB race.
2. according to claim 1 for increasing bone density and the composition of develop immunitypty, it is characterized in that, by its weight parts collagen peptide 20-50 part, enzymolysis bone meal 20-40 part, first milk basic protein 0.5-2.5 part, vitamin 0.05-0.8 part, mineral matter 0.05-0.8 part.
3. according to claim 1 for increasing bone density and the composition of develop immunitypty, it is characterized in that, by its weight parts collagen peptide 30-40 part, enzymolysis bone meal 25-35 part, first milk basic protein 1-2 part, vitamin 0.1-0.5 part, mineral matter 0.1-0.5 part.
4. according to claim 1 for increasing bone density and the composition of develop immunitypty, it is characterized in that, by its weight parts collagen peptide 15 parts, enzymolysis bone meal 15 parts, first milk basic protein 1 part, vitamin 0.1 part, 0.1 part, mineral matter.
5. according to claim 1 for increasing bone density and the composition of develop immunitypty, it is characterized in that, described mineral matter is made up of calcium, zinc, magnesium, copper, chromium and iron, by its weight parts calcium 80 parts, 1 part, zinc, 15 parts, magnesium, copper 0.1 part, chromium 0.01 part.
6. according to claim 1 for increasing bone density and the composition of develop immunitypty, it is characterized in that, described vitamin is made up of VA, VC, VD, VE, VK, by its weight parts VA10 part, VC1000 part, VD0.1 part, VE1000 part, VK1 part.
7. according to the arbitrary claim of claim 1-6 for increasing bone density and the composition of develop immunitypty, it is characterized in that, also comprise the auxiliary material of following weight portion: cereal reconstitutes powder 1-95 part, crystal diabetin 1-50 part, Fruit powder 1-40 part, maltodextrin 1-20 part, silica 0.1-2 part.
8. according to claim 7 for increasing bone density and the composition of develop immunitypty, it is characterized in that, described Fruit powder is one or more in apple powder, kiwi fruit powder, mangosteen powder, coconut powder, mango powder, passionflower powder, pineapple powder, honey peach powder, manaca powder, acerola concentrate powder, A Sayi fruit powder, grape fruit powder, guava powder, lemon powder, strawberry powder, dragon fruit powder.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201511025471.9A CN105533712A (en) | 2015-12-29 | 2015-12-29 | Composition used for increasing bone density and enhancing immunity |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201511025471.9A CN105533712A (en) | 2015-12-29 | 2015-12-29 | Composition used for increasing bone density and enhancing immunity |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CN105533712A true CN105533712A (en) | 2016-05-04 |
Family
ID=55813707
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN201511025471.9A Pending CN105533712A (en) | 2015-12-29 | 2015-12-29 | Composition used for increasing bone density and enhancing immunity |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN105533712A (en) |
Cited By (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN105996049A (en) * | 2016-06-15 | 2016-10-12 | 天津天狮生物发展有限公司 | Child instant medicine for boosting immunity |
| CN105996059A (en) * | 2016-06-15 | 2016-10-12 | 天津天狮生物发展有限公司 | Composition for increasing bone mineral density |
| CN107927511A (en) * | 2017-12-14 | 2018-04-20 | 苏州维高能生物技术有限公司 | A kind of nutrition-balanced solid beverage |
| CN108576816A (en) * | 2018-03-09 | 2018-09-28 | 黑龙江飞鹤乳业有限公司 | A kind of composition increasing bone density |
| CN108968075A (en) * | 2018-07-05 | 2018-12-11 | 天津市益倍建生物技术有限公司 | It is a kind of improve bone health composition and its application |
| CN112956702A (en) * | 2021-03-25 | 2021-06-15 | 江西邦泰绿色生物合成生态产业园发展有限公司 | Compound preparation for increasing bone mineral density |
-
2015
- 2015-12-29 CN CN201511025471.9A patent/CN105533712A/en active Pending
Cited By (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN105996049A (en) * | 2016-06-15 | 2016-10-12 | 天津天狮生物发展有限公司 | Child instant medicine for boosting immunity |
| CN105996059A (en) * | 2016-06-15 | 2016-10-12 | 天津天狮生物发展有限公司 | Composition for increasing bone mineral density |
| CN107927511A (en) * | 2017-12-14 | 2018-04-20 | 苏州维高能生物技术有限公司 | A kind of nutrition-balanced solid beverage |
| CN108576816A (en) * | 2018-03-09 | 2018-09-28 | 黑龙江飞鹤乳业有限公司 | A kind of composition increasing bone density |
| CN108968075A (en) * | 2018-07-05 | 2018-12-11 | 天津市益倍建生物技术有限公司 | It is a kind of improve bone health composition and its application |
| CN112956702A (en) * | 2021-03-25 | 2021-06-15 | 江西邦泰绿色生物合成生态产业园发展有限公司 | Compound preparation for increasing bone mineral density |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN105533712A (en) | Composition used for increasing bone density and enhancing immunity | |
| CN102160614B (en) | Compound preparation for improving immunity of human bodies and enhancing bone density and application thereof | |
| CN100548156C (en) | Energy stick | |
| CN103083648B (en) | Troche for enhancing bone mineral density based on milk mineral salt as raw material as well as preparation method thereof | |
| CN102805858B (en) | High-efficiency calcium supplement capsule and preparation method thereof | |
| CN102318835A (en) | Composition for reducing bone loss and preparation method thereof | |
| CN104982937B (en) | It is a kind of to promote sclerotin and the composition of periosteum for repairing and preparation method thereof | |
| CN102178932B (en) | Preparation for relieving fatigue and enhancing immunity | |
| CN107708683A (en) | Amino acid supplementation | |
| CN102415447B (en) | Calcium supplement electuary for infants and preparation process thereof | |
| CN103734582A (en) | Yak lactoprotein polypeptide nutrition powder applicable to middle-aged and aged people and preparation method of powder | |
| CN103039976A (en) | Healthcare food for increasing bone density and preparation method thereof | |
| CN102613297B (en) | Milk for enhancing organism immunity and preparation process of milk | |
| CN103141892A (en) | Cucumber seed beverage and preparation method and application thereof | |
| Akpantah et al. | The effect of calabash chalk on some hematological parameters in female adult Wistar rats | |
| CN104489681A (en) | Composition with function of enhancing immunity, health product and preparation method thereof | |
| CN101279089B (en) | Donkey-hide gelatin calcium composition and preparing process thereof | |
| Dolphin et al. | Maternal diets, nutritional status, and zinc in contemporary Mexican infants' teeth: Implications for reconstructing paleodiets | |
| CN104222280A (en) | Solid beverage capable of increasing body immunity of infants and production method of solid beverage | |
| CN106417619A (en) | Milk calcium powder for promoting skeleton growth and enhancing immunity | |
| CN103690564A (en) | Application of wood frog high protein calcium powder in preparation of anti-fatigue health-care products or drugs | |
| CN108968075A (en) | It is a kind of improve bone health composition and its application | |
| CN101292704B (en) | Se-enriched feedstuff containing selenium element and uses thereof | |
| CN105996059A (en) | Composition for increasing bone mineral density | |
| Ara et al. | Proximate analysis of local and Thai climbing perch, Anabas testudineus |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| C06 | Publication | ||
| PB01 | Publication | ||
| WD01 | Invention patent application deemed withdrawn after publication | ||
| WD01 | Invention patent application deemed withdrawn after publication |
Application publication date: 20160504 |